Vietnam Investments Group

Vietnam Investments Group is a Ho Chi Minh City-based major local private equity firm targeting high-growth middle-market enterprises across Vietnam, with healthcare exposure focused on care delivery and tech-enabled health services. Check sizes of $5M to $25M and a growth-stage focus place the firm well above the venture range; this is a firm for Vietnamese healthcare operators with substantial commercial scale, not for early-stage technology founders. The firm is not specifically AI-focused.

The firm’s natural fit is with Vietnamese healthcare operators running revenue-scale operations across hospital and clinic chains, diagnostics, pharmacy and pharmaceutical distribution, and tech-enabled care delivery with proven unit economics. The right CEO profile is a seasoned operator with audited financials, a credible board, and a clear thesis on how growth capital expands a defined market position. Pre-revenue founders, early Series A teams, and pure software AI plays are not the right fit.

Geographically, the firm’s advantage is the Vietnamese market itself, which is one of the fastest-growing economies in Southeast Asia and a market with significant healthcare infrastructure investment opportunities. The firm’s local network into Vietnamese corporate, regulatory, and family-office stakeholders is a meaningful asset for founders navigating the local environment. For non-Vietnamese operators, the strategic logic is thin.

The right entry path is via an investment banker leading the round, an existing growth-stage co-investor, or a board member with senior Vietnamese operating experience. Decks should lead with audited financial history, growth metrics, market position, and a specific use of capital tied to a discrete commercial milestone. Be prepared for multi-month diligence including site visits, regulatory reviews, and management background checks.

Caveats. Growth equity introduces governance complexity, including specific protective provisions, drag-along rights, and exit timing expectations; engage experienced PE-track counsel from the start. Vietnamese fund structures and FX dynamics complicate cross-border rounds; engage regional counsel. The firm’s healthcare-specific portfolio depth is not as concentrated as that of pure-play healthcare PE funds; reference calls with portfolio operators are essential. For Vietnamese healthcare operators at growth scale, Vietnam Investments Group is a credible domestic PE partner; for venture-stage technology founders or non-Vietnamese operators, this is the wrong door.